60 Degrees Pharmaceuticals, LLC (60P), a pharmaceutical company focused on developing new medicines for tropical diseases, announced today that initial testing in cell culture shows that ARAKODA (tafenoquine) is active against SARS-CoV-2 at clinically relevant concentrations.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,